SEC Form 4 · accession 0001209191-18-038059
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy R Franson
Director
Period of report
Jun 13, 2018
Accepted (ET)
Jun 15, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.30 | Jun 13, 2018 | A | 11,000 | A | — | Jun 12, 2028 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2019 annual meeting of stockholders.